Brain tumours may express high levels of SSTRs, in particular meningiomas (90% of them express SSTR2) [5,23,24,25], but also astrocytomas and gliomas [5,26,27,28,29], making such tumours amenable to PRRT. Here, SSTR2 is linked to brain neoplasm.